Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
Countdown to BioMarin (BMRN) Q4 Earnings: Wall Street Forecasts for Key Metrics
10:16am, Thursday, 19'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
SAN RAFAEL, Calif., Feb. 17, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a confe
What to Expect From These Drug/Biotech Players This Earnings Season?
03:16pm, Monday, 16'th Feb 2026
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.
BioMarin Announces Closing of Private Offering of Senior Notes
04:05pm, Thursday, 12'th Feb 2026
SAN RAFAEL, Calif., Feb. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it closed its previously announced offering of $850 million of 5.500% se
Earnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to Decline
11:02am, Wednesday, 11'th Feb 2026
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plato Investment Management Ltd Boosts Holdings in BioMarin Pharmaceutical Inc. $BMRN
03:22am, Monday, 09'th Feb 2026
Plato Investment Management Ltd increased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 59.5% in the third quarter, according to its most recent 13F filing with the SEC. The instituti
Principal Financial Group Inc. Sells 13,638 Shares of BioMarin Pharmaceutical Inc. $BMRN
04:29am, Sunday, 08'th Feb 2026
Principal Financial Group Inc. cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 3.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securitie
BioMarin Pharmaceutical Inc. $BMRN Shares Purchased by Savant Capital LLC
03:32am, Saturday, 07'th Feb 2026
Savant Capital LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 54.4% during the third quarter, according to the company in its most recent filing with the Securities and Exch
Callan Family Office LLC Has $2.27 Million Holdings in BioMarin Pharmaceutical Inc. $BMRN
03:08am, Thursday, 05'th Feb 2026
Callan Family Office LLC decreased its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 37.5% during the undefined quarter, according to the company in its most recent disclosure with
BioMarin Pharmaceutical Inc. $BMRN Shares Purchased by Mediolanum International Funds Ltd
03:12am, Tuesday, 03'rd Feb 2026
Mediolanum International Funds Ltd boosted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 56.2% during the undefined quarter, according to its most recent 13F filing with the
The Right Play On BioMarin Pharmaceuticals
06:17am, Sunday, 01'st Feb 2026
BioMarin Pharmaceuticals recently announced it is acquiring Amicus Therapeutics for $4.8B, adding two rare disease assets with blockbuster potential and strategic synergies. The acquisition provides i
Should You Buy BioMarin Pharmaceutical Before Feb. 18?
04:44am, Saturday, 31'st Jan 2026
BioMarin expects strong sales for its rare-disease drug, Voxzogo, in Q4. The company also has several important catalysts on the way in the first half of the year.
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
04:05pm, Thursday, 29'th Jan 2026
SAN RAFAEL, Calif., Jan. 29, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it priced its previously announced offering of $850 million of 5.500% se
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
07:45am, Monday, 26'th Jan 2026
SAN RAFAEL, Calif., Jan. 26, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it intends to offer, subject to market and other conditions, $850 millio
Campbell & CO Investment Adviser LLC Trims Stake in BioMarin Pharmaceutical Inc. $BMRN
04:29am, Tuesday, 20'th Jan 2026
Campbell and CO Investment Adviser LLC cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 75.6% in the third quarter, according to the company in its most recent filing with
